Literature DB >> 11376826

The prognostic significance of intermediate QRS prolongation in acute myocardial infarction.

R Pudil1, M S Feinberg, H Hod, V Boyko, L Mandelzweig, S Behar.   

Abstract

Complete right and left bundle branch block and advanced atrioventricular block present on admission electrocardiograms of patients with acute myocardial infarction, are associated with poor short and long-term outcome. Little is known about the impact of intermediate QRS prolongation (0.09-0.11 s) on the prognosis of acute myocardial infarction. In this study, among 1100 consecutive patients with acute myocardial infarction treated with thrombolysis, the QRS duration on admission electrocardiogram was <0.09 s in 536 (48%) patients, between 0.09 and 0.11 s in 496 (45%) patients and >0.11 s in 78 (7%) patients. QRS duration was strongly associated with 7-day (0.6%, 6%,18%, P<0.001), 30-day (1%, 8%, 22%, P<0.001) and 1-year (3%, 11%, 26%, P<0.001) all-cause mortality. After adjustment for significant variables associated with 1-year mortality, including age, female gender, diabetes mellitus, systemic hypertension, previous myocardial infarction, anterior myocardial infarction and Killip class> or =2 on admission, both levels of QRS prolongation remained significant independent predictors of short and long-term all-cause mortality.

Entities:  

Mesh:

Year:  2001        PMID: 11376826     DOI: 10.1016/s0167-5273(01)00379-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Prolonged QRS independently predicts long-term all-cause mortality in patients with narrow QRS complex undergoing coronary artery bypass grafting surgery (9-year follow-up results).

Authors:  Turan Erdoğan; Mustafa Çetin; Ali Gökhan Özyıldız; Savaş Özer; Abdülkadir Uslu; Sedat Ozan Karakişi; Tuncay Kırış
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-09-23

2.  A new simplified immediate prognostic risk score for patients with acute myocardial infarction.

Authors:  B A Williams; R S Wright; J G Murphy; E S Brilakis; G S Reeder; A S Jaffe
Journal:  Emerg Med J       Date:  2006-03       Impact factor: 2.740

3.  In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine.

Authors:  Sergiy M Nadtochiy; Lindsay S Burwell; Christopher A Ingraham; Cody M Spencer; Alan E Friedman; Carl A Pinkert; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2009-02-03       Impact factor: 5.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.